Squarepoint’s Achieve Life Sciences QUIT Stock Holding History

Squarepoint’s Portfolio QUIT Stock Details QUIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$830K	Buy	+102,572	New	+$734K	﹤0.01%	2931
2026 Q2	–	Sell	-19,658	Closed	-$57.8K	–	4332
2026 Q1	$57.8K	Sell	19,658 -144,947	-88%	-$644K	﹤0.01%	4127
2025 Q4	$818K	Sell	164,605 -208,474	-56%	-$909K	﹤0.01%	2780
2025 Q3	$1.18M	Buy	373,079 +359,642	+2,677%	+$987K	﹤0.01%	2550
2025 Q2	$30.4K	Buy	+13,437	New	+$38.3K	﹤0.01%	4361
2025 Q1	–	Sell	-17,519	Closed	-$61.7K	–	4481
2024 Q4	$61.7K	Buy	+17,519	New	+$79.4K	﹤0.01%	4807
2024 Q1	–	Sell	-23,105	Closed	-$95.2K	–	3944
2023 Q4	$95.2K	Buy	23,105 +10,631	+85%	+$46.3K	﹤0.01%	3761
2023 Q3	$53.6K	Sell	12,474 -9,498	-43%	-$47.9K	﹤0.01%	3630
2023 Q2	$114K	Buy	+21,972	New	+$154K	﹤0.01%	3340
2020 Q4	–	Sell	-10,093	Closed	-$84K	–	2858
2020 Q3	$84K	Buy	+10,093	New	+$92.6K	﹤0.01%	2315

Other funds holding QUIT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Squarepoint's QUIT Position: Q3 2026 in Review

Squarepoint opened a new position in Achieve Life Sciences (QUIT) in Q3 2026: 102,572 shares worth $830K. The stake represents ﹤0.01% of the portfolio and ranks #2931 among its holdings. This is a return to the name: Squarepoint previously reported a position in QUIT as recently as Q1 2026.

Squarepoint first reported a position in QUIT in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.18M in Q3 2025. 42 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

Squarepoint held 102,572 shares of Achieve Life Sciences worth $830K as of Q3 2026.
Achieve Life Sciences was a new Squarepoint position in Q3 2026.
Achieve Life Sciences made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #2931 holding.
Squarepoint first reported a position in Achieve Life Sciences in Q3 2020 and has held it in 10 quarters since.
Squarepoint's Achieve Life Sciences position peaked at $1.18M in Q3 2025.
42 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.